Veracyte builds molecular diagnostics that sit at the intersection of genomics and clinical decision-making - tools that help oncologists and pathologists determine whether a patient's cancer requires aggressive treatment or can be safely monitored. The company operates out of South San Francisco, CA, and Austin, TX, developing genomic tests across cancer diagnostics and precision medicine. That means the threat surface isn't hypothetical: genomic data, patient health records, and proprietary diagnostic algorithms all demand rigorous protection.
From a security standpoint, a diagnostics company handling genomic and clinical data faces a specific set of challenges. HIPAA compliance is table stakes, but the real complexity lies in protecting the integrity of molecular diagnostic pipelines - where a data integrity failure isn't just a breach notification but a potential misdiagnosis. The attack surface spans cloud infrastructure hosting bioinformatics workloads, integration points with healthcare systems, and the proprietary datasets that power precision medicine algorithms.
Veracyte's culture signals emphasize a purpose-driven environment with stated values around continuous improvement and collaborative problem-solving. The company is publicly traded and positions itself as committed to creating space where team members can impact patient outcomes while building their careers - relevant context for security professionals who want to work in environments where the stakes are tangible and the mission is concrete rather than abstract.
